Patents by Inventor Maki Nakayama

Maki Nakayama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds that modulate autoimmunity and methods of using the same
    Patent number: 9629848
    Abstract: The invention provides methods of preventing, treating or ameliorating autoimmune diseases, such as diabetes and celiac disease, by decreasing the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease by the administration of small organic compounds. The invention also provides pharmaceutical compositions comprising the therapeutically effective small organic compounds and methods of using the same.
    Type: Grant
    Filed: May 29, 2012
    Date of Patent: April 25, 2017
    Assignees: The Regents of the University of Colorado, a body corporate, The University of Florida Research Foundation Incorporated
    Inventors: Aaron Michels, Maki Nakayama, David Ostrov
  • COMPOUNDS THAT MODULATE AUTOIMMUNITY AND METHODS OF USING THE SAME
    Publication number: 20150038480
    Abstract: The invention provides methods of preventing, treating or ameliorating autoimmune diseases, such as diabetes and celiac disease, by decreasing the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease by the administration of small organic compounds. The invention also provides pharmaceutical compositions comprising the therapeutically effective small organic compounds and methods of using the same.
    Type: Application
    Filed: May 29, 2012
    Publication date: February 5, 2015
    Applicants: UNIVERSITY OF FLORIDA RESERCH FOUNDATION INCORPORTED, THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate
    Inventors: Aaron Michels, Maki Nakayama, David Ostrov
  • COMPOUNDS THAT MODULATE AUTOIMMUNITY AND METHODS OF USING THE SAME
    Publication number: 20120195929
    Abstract: The invention provides methods of preventing, treating or ameliorating autoimmune diseases such as diabetes by modulating the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease by the administration of small organic compounds. The invention also provides pharmaceutical compositions comprising the therapeutically effective small organic compounds and methods of using the same.
    Type: Application
    Filed: June 4, 2010
    Publication date: August 2, 2012
    Inventors: George Eisenbarth, Aaron Michels, David Ostrov, Maki Nakayama